Axel Heidenreich


Ontology type: schema:Person     


Person Info

NAME

Axel

SURNAME

Heidenreich

Publications in SciGraph latest 50 shown

  • 2019-12 Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program in BMC CANCER
  • 2019-03 Androgen-targeted therapy in men with prostate cancer: evolving practice and future considerations in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2019-02 Lehrforschung in der Urologie in DER UROLOGE
  • 2019 Management of Metastatic Castration-Naïve Prostate Cancer in UROLOGIC ONCOLOGY
  • 2019-01 SIU–ICUD consultation on bladder cancer: treatment of muscle-invasive bladder cancer in WORLD JOURNAL OF UROLOGY
  • 2018-12-13 Predictors of thrombosis in testicular cancer during platinum-based chemotherapy in WORLD JOURNAL OF UROLOGY
  • 2018-12 Testicular Cancer on the Web—an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines? in JOURNAL OF CANCER EDUCATION
  • 2018-12 Comprehensive pharmaceutical care to prevent drug-related readmissions of dependent-living elderly patients: a randomized controlled trial in BMC GERIATRICS
  • 2018-12 External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma in WORLD JOURNAL OF UROLOGY
  • 2018-10-19 Comparison of adjustable male slings and artificial urinary sphincter in the treatment of male urinary incontinence: a retrospective analysis of patient selection and postoperative continence status in WORLD JOURNAL OF UROLOGY
  • 2018-09 Grenzen der Chirurgie in der Uroonkologie in DER UROLOGE
  • 2018-08-13 Combined Early and Late [68Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels in MOLECULAR IMAGING AND BIOLOGY
  • 2018-08 Substantial utilization of Facebook, Twitter, YouTube, and Instagram in the prostate cancer community in WORLD JOURNAL OF UROLOGY
  • 2018-07 Advanced Prostate Cancer Consensus Conference 2017 in DER UROLOGE
  • 2018-06 Thromboprophylaxis and the route of administration of chemotherapy in testicular cancer patients in German-speaking countries in WORLD JOURNAL OF UROLOGY
  • 2018-04 Current approaches to incorporation of radium-223 in clinical practice in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2018-01-08 Websites on Bladder Cancer: an Appropriate Source of Patient Information? in JOURNAL OF CANCER EDUCATION
  • 2018-01 Metastasiertes kastrationsresistentes Prostatakarzinom in DER UROLOGE
  • 2017-12 Antiangiogenic therapies in urogenital malignancies in MEMO - MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY
  • 2017-08 Lungenmetastasenchirurgie beim Nierenzellkarzinom in DER UROLOGE
  • 2017-07 Ein erfolgreicher Auftakt zum 1. Kölner OP-Workshop der GeSRU in DER UROLOGE
  • 2017-05 Wann ist die operative Versorgung von Metastasen beim testikulären Keimzelltumor angezeigt und gibt es eine wissenschaftliche Grundlage dafür? in DER UROLOGE
  • 2017-03 The role of salvage extended lymph node dissection in patients with rising PSA and PET/CT scan detected nodal recurrence of prostate cancer in PROSTATE CANCER AND PROSTATIC DISEASES
  • 2017-03 Sekundärmalignome nach perkutaner Radiotherapie in DER UROLOGE
  • 2017-02 New Biomarkers for Selecting the Best Therapy Regimens in Metastatic Castration-Resistant Prostate Cancer in TARGETED ONCOLOGY
  • 2017 Follow-Up After Radical Treatments and Relapse in MANAGEMENT OF PROSTATE CANCER
  • 2016-12 TNM-Klassifikation des lokalisierten Prostatakarzinoms in DER UROLOGE
  • 2016-11 1. Kölner OP-Workshop – Verbessere deine operativen Fähigkeiten! in DER UROLOGE
  • 2016-11 Prostate cancer: Estimated life expectancy: integration of age and comorbidities in NATURE REVIEWS UROLOGY
  • 2016-09 Kommende urologische Problemfelder und Lösungsideen in URO-NEWS
  • 2016-08 Resection of metastasis and local recurrences of renal cell carcinoma after presurgical targeted therapy: probability of complete local control and outcome in WORLD JOURNAL OF UROLOGY
  • 2016-08 Facharztweiterbildung in der Niederlassung in DER UROLOGE
  • 2016-07 Detection of recurrent prostate cancer lesions before salvage lymphadenectomy is more accurate with 68Ga-PSMA-HBED-CC than with 18F-Fluoroethylcholine PET/CT in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-06 Advanced Prostate Cancer Consensus Conference (APCCC) 2015 in St. Gallen in DER UROLOGE
  • 2016-05 Postchemotherapeutische Residualtumorresektion komplexer Metastasenlokalisationen fortgeschrittener testikulärer Keimzelltumoren in DER UROLOGE
  • 2016-03 Extent of disease in recurrent prostate cancer determined by [68Ga]PSMA-HBED-CC PET/CT in relation to PSA levels, PSA doubling time and Gleason score in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • 2016-03 Multimodale Therapie des lokal fortgeschrittenen Prostatakarzinoms in DER UROLOGE
  • 2016-02 Lebensqualität von Patienten mit Prostatakarzinom unter Androgendeprivation mit GnRH-Analoga in DER UROLOGE
  • 2016-02 Analysis of drug-related problems in three departments of a German University hospital in INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
  • 2016 Therapie des metastasierten Hodentumors in DIE UROLOGIE
  • 2015-11 Versorgungsabbild zum Prostatakarzinom in DVPZ-Prostatazentren in Deutschland in DER UROLOGE
  • 2015-10 Reduzierte Morbidität bei der Resektion von Residualtumoren nach Chemotherapie beim Seminom in DER UROLOGE
  • 2015-08 Der Arbeitskreis „Angestellte Ärzte“ im BDU in DER UROLOGE
  • 2015-05 Prostate cancer: Sequencing AR-targeted agents might be ineffective in mCRPC in NATURE REVIEWS UROLOGY
  • 2015-04 In cystectomy specimens with bladder cancer whole organ embedding increases the detection rate of histopathological parameters, but not of those with prognostic significance in VIRCHOWS ARCHIV
  • 2015 Testicular Cancer- Clinical Features, Staging and Surgical Management in UROLOGICAL ONCOLOGY
  • 2015-01 Zytoreduktive radikale Prostatektomie beim Prostatakarzinom mit minimaler ossärer Metastasierung in DER UROLOGE
  • 2015 Therapie des metastasierten Hodentumors in DIE UROLOGIE
  • 2014-12 A randomized, double-blind, placebo-controlled, Phase I/II trial of RNActive®-vaccine cv9104 in patients with metastatic castrate-refractory prostate cancer (mcrpc): first results of the Phase I part in JOURNAL FOR IMMUNOTHERAPY OF CANCER
  • 2014-12 Vielversprechendes Diagnostikum für urologische Tumoren in URO-NEWS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.411097.a", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415600.6", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1957.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5949.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415445.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.491994.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10253.35", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412301.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5386.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5718.b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5570.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.478023.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.492834.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419824.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.17089.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.9647.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.248762.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.22937.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.6190.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413574.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5603.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5645.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.8664.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.265436.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10388.32", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411327.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419513.b", 
            "type": "Organization"
          }
        ], 
        "familyName": "Heidenreich", 
        "givenName": "Axel", 
        "id": "sg:person.0735602015.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735602015.61"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:48", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_543.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0735602015.61'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0735602015.61'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0735602015.61'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0735602015.61'


     

    This table displays all metadata directly associated to this object as RDF triples.

    68 TRIPLES      10 PREDICATES      37 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0735602015.61 schema:affiliation Nd715cea813174307b0980bc5a49a97cd
    2 https://www.grid.ac/institutes/grid.10253.35
    3 https://www.grid.ac/institutes/grid.10388.32
    4 https://www.grid.ac/institutes/grid.17089.37
    5 https://www.grid.ac/institutes/grid.1957.a
    6 https://www.grid.ac/institutes/grid.22937.3d
    7 https://www.grid.ac/institutes/grid.248762.d
    8 https://www.grid.ac/institutes/grid.265436.0
    9 https://www.grid.ac/institutes/grid.411327.2
    10 https://www.grid.ac/institutes/grid.412301.5
    11 https://www.grid.ac/institutes/grid.413574.0
    12 https://www.grid.ac/institutes/grid.415445.5
    13 https://www.grid.ac/institutes/grid.415600.6
    14 https://www.grid.ac/institutes/grid.419513.b
    15 https://www.grid.ac/institutes/grid.419824.2
    16 https://www.grid.ac/institutes/grid.478023.a
    17 https://www.grid.ac/institutes/grid.491994.8
    18 https://www.grid.ac/institutes/grid.492834.0
    19 https://www.grid.ac/institutes/grid.5386.8
    20 https://www.grid.ac/institutes/grid.5570.7
    21 https://www.grid.ac/institutes/grid.5603.0
    22 https://www.grid.ac/institutes/grid.5645.2
    23 https://www.grid.ac/institutes/grid.5718.b
    24 https://www.grid.ac/institutes/grid.5949.1
    25 https://www.grid.ac/institutes/grid.6190.e
    26 https://www.grid.ac/institutes/grid.8664.c
    27 https://www.grid.ac/institutes/grid.9647.c
    28 schema:familyName Heidenreich
    29 schema:givenName Axel
    30 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735602015.61
    31 schema:sdDatePublished 2019-03-07T14:48
    32 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    33 schema:sdPublisher N9c7742fdbd8043d4bccf17b955a598a1
    34 sgo:license sg:explorer/license/
    35 sgo:sdDataset persons
    36 rdf:type schema:Person
    37 N9c7742fdbd8043d4bccf17b955a598a1 schema:name Springer Nature - SN SciGraph project
    38 rdf:type schema:Organization
    39 Nd715cea813174307b0980bc5a49a97cd schema:affiliation https://www.grid.ac/institutes/grid.411097.a
    40 sgo:isCurrent true
    41 rdf:type schema:OrganizationRole
    42 https://www.grid.ac/institutes/grid.10253.35 schema:Organization
    43 https://www.grid.ac/institutes/grid.10388.32 schema:Organization
    44 https://www.grid.ac/institutes/grid.17089.37 schema:Organization
    45 https://www.grid.ac/institutes/grid.1957.a schema:Organization
    46 https://www.grid.ac/institutes/grid.22937.3d schema:Organization
    47 https://www.grid.ac/institutes/grid.248762.d schema:Organization
    48 https://www.grid.ac/institutes/grid.265436.0 schema:Organization
    49 https://www.grid.ac/institutes/grid.411097.a schema:Organization
    50 https://www.grid.ac/institutes/grid.411327.2 schema:Organization
    51 https://www.grid.ac/institutes/grid.412301.5 schema:Organization
    52 https://www.grid.ac/institutes/grid.413574.0 schema:Organization
    53 https://www.grid.ac/institutes/grid.415445.5 schema:Organization
    54 https://www.grid.ac/institutes/grid.415600.6 schema:Organization
    55 https://www.grid.ac/institutes/grid.419513.b schema:Organization
    56 https://www.grid.ac/institutes/grid.419824.2 schema:Organization
    57 https://www.grid.ac/institutes/grid.478023.a schema:Organization
    58 https://www.grid.ac/institutes/grid.491994.8 schema:Organization
    59 https://www.grid.ac/institutes/grid.492834.0 schema:Organization
    60 https://www.grid.ac/institutes/grid.5386.8 schema:Organization
    61 https://www.grid.ac/institutes/grid.5570.7 schema:Organization
    62 https://www.grid.ac/institutes/grid.5603.0 schema:Organization
    63 https://www.grid.ac/institutes/grid.5645.2 schema:Organization
    64 https://www.grid.ac/institutes/grid.5718.b schema:Organization
    65 https://www.grid.ac/institutes/grid.5949.1 schema:Organization
    66 https://www.grid.ac/institutes/grid.6190.e schema:Organization
    67 https://www.grid.ac/institutes/grid.8664.c schema:Organization
    68 https://www.grid.ac/institutes/grid.9647.c schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...